A subset of cMet+ CD8+ T cells have been identified in murine tumor models and melanoma patients, where cMet expression is associated with increased cytolytic capacity and effector functions including IFNγ/TNFα and granzyme B/perforin production [40]. The gene discussed is CD8A; the disease is melanoma.